Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts

Rafke Schoffelen, Robert M. Sharkey, David M. Goldenberg, Gerben Franssen, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, Peter Laverman, Jonathan A. Disselhorst, Annemarie Eek, Winette T.A. van der Graaf, Wim J.G. Oyen and Otto C. Boerman
Rafke Schoffelen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert M. Sharkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Goldenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerben Franssen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William J. McBride
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edmund A. Rossi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chien-Hsing Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Laverman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan A. Disselhorst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemarie Eek
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winette T.A. van der Graaf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim J.G. Oyen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto C. Boerman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-09-0862 Published April 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: March 2010 to March 2021

AbstractFull-text HTMLPDF
Total267420811484

Cited By

Article Information

Volume 9, Issue 4, pp. 1019-1027

DOI 
https://doi.org/10.1158/1535-7163.MCT-09-0862
PubMed 
20354120

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received September 15, 2009
  • Revision received January 18, 2010
  • Accepted January 25, 2010
  • Published first March 30, 2010.

Article Versions

  • Previous version (March 30, 2010 - 08:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2010 American Association for Cancer Research.

Author Information

  1. Rafke Schoffelen1,
  2. Robert M. Sharkey3,
  3. David M. Goldenberg3,
  4. Gerben Franssen1,
  5. William J. McBride4,
  6. Edmund A. Rossi5,
  7. Chien-Hsing Chang4,5,
  8. Peter Laverman1,
  9. Jonathan A. Disselhorst1,
  10. Annemarie Eek1,
  11. Winette T.A. van der Graaf2,
  12. Wim J.G. Oyen1 and
  13. Otto C. Boerman1
  1. Authors' Affiliations: Departments of 1Nuclear Medicine and 2Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; 3Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, New Jersey; and 4IBC Pharmaceuticals, Inc.; 5Immunomedics, Inc., Morris Plains, New Jersey
  1. Corresponding Author:
    Rafke Schoffelen, Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. Phone: 31-24-3619097; Fax: 31-24-3618942. E-mail: r.schoffelen{at}nucmed.umcn.nl
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 9 (4)
April 2010
Volume 9, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
Rafke Schoffelen, Robert M. Sharkey, David M. Goldenberg, Gerben Franssen, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, Peter Laverman, Jonathan A. Disselhorst, Annemarie Eek, Winette T.A. van der Graaf, Wim J.G. Oyen and Otto C. Boerman
Mol Cancer Ther April 1 2010 (9) (4) 1019-1027; DOI: 10.1158/1535-7163.MCT-09-0862

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
Rafke Schoffelen, Robert M. Sharkey, David M. Goldenberg, Gerben Franssen, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, Peter Laverman, Jonathan A. Disselhorst, Annemarie Eek, Winette T.A. van der Graaf, Wim J.G. Oyen and Otto C. Boerman
Mol Cancer Ther April 1 2010 (9) (4) 1019-1027; DOI: 10.1158/1535-7163.MCT-09-0862
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • PX-478 Radiosensitization in Pancreatic Cancer
  • Metronomic Gemcitabine Inhibits Pancreatic Cancer
  • p53-Deficient Cells Are More Sensitive to Plk1 Inhibitor
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement